These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35768308)

  • 1. Pharmacist interventions to deprescribe benzodiazepines in older adults: A missed opportunity?
    Cadogan CA
    Res Social Adm Pharm; 2022 Nov; 18(11):4012-4015. PubMed ID: 35768308
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis.
    Melo TAR; Bezerra CO; Fernandes BD; Rotta I; Reis WCT; Aguiar PM
    Int J Clin Pharm; 2023 Oct; 45(5):1037-1049. PubMed ID: 37713028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.
    Ng BJ; Le Couteur DG; Hilmer SN
    Drugs Aging; 2018 Jun; 35(6):493-521. PubMed ID: 29705831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people.
    Reeve E; Ong M; Wu A; Jansen J; Petrovic M; Gnjidic D
    Eur J Clin Pharmacol; 2017 Aug; 73(8):927-935. PubMed ID: 28456823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Medication Deprescribing in the Elderly: Results of a Pharmacist-Driven Procedure in a Transitional Care Unit.
    Feldman EA; Noviasky J; Ulen KR; Miller CD; Barbagallo D; Seabury R
    Sr Care Pharm; 2019 Dec; 34(10):678-686. PubMed ID: 31818354
    [No Abstract]   [Full Text] [Related]  

  • 10. Deprescribing in frail older people--Do doctors and pharmacists agree?
    Page AT; Etherton-Beer CD; Clifford RM; Burrows S; Eames M; Potter K
    Res Social Adm Pharm; 2016; 12(3):438-49. PubMed ID: 26453002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITU patients with delirium did not benefit from electronic and pharmacist support encouraging the deprescribing of benzodiazepines and anticholinergics.
    Donaghy J
    Evid Based Nurs; 2020 Apr; 23(2):52. PubMed ID: 31285247
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
    Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
    Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists.
    McCarthy M; Mak S; Kaufmann CN; Lum HD; Fung CH
    Res Social Adm Pharm; 2022 Apr; 18(4):2691-2694. PubMed ID: 34229951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pharmacist-led Deprescribing Intervention with the Functional Recovery in Convalescent Setting.
    Kose E; Endo H; Hori H; Hosono S; Kawamura C; Kodama Y; Yamazaki T; Yasuno N
    Pharmazie; 2022 May; 77(5):165-170. PubMed ID: 35655381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study.
    Jokanovic N; Aslani P; Carter S; Duong M; Gnjidic D; Jansen J; Le Couteur D; Hilmer S
    BMJ Open; 2019 Dec; 9(12):e033303. PubMed ID: 31831548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting.
    Ó Ciardha D; Blake AM; Creane D; Callaghan MÓ; Darker C
    BMJ Open; 2022 May; 12(5):e050261. PubMed ID: 35623753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.